Ayala Pharmaceuticals, Inc. — Form D

Ayala Pharmaceuticals, Inc. of MONMOUTH JUNCTION, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-11. The offering totals $4.8M, of which $4.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (40)

Showing 25 of 40 people.

NameRoleLocation
Roni AppelDirectorMonmouth Junction, NJ
Kenneth BerlinDirectorMonmouth Junction, NJ
Richard BermanDirectorMerritt Island, FL
Samir KhleifDirectorMonmouth Junction, NJ
James PattonDirectorMonmouth Junction, NJ
David SidranskyDirectorGermantown, MD
Kenneth BerlinExecutive OfficerMonmouth Junction, NJ
Igor GitelmanExecutive OfficerMonmouth Junction, NJ
Andres GutierrezExecutive OfficerMonmouth Junction, NJ
Thomas MooreDirectorFranklin, TN
Thomas MooreExecutive OfficerFranklin, TN
Mark J RosenblumExecutive OfficerHouston, TX
Andres A GutierrezExecutive OfficerMONMOUTH JUNCTION, NJ
Igor A GitelmanExecutive OfficerMONMOUTH JUNCTION, NJ
Pini A OrbachDirectorMONMOUTH JUNCTION, NJ
Murray A GoldbergDirectorMONMOUTH JUNCTION, NJ
Vered A Bisker-LeibDirectorMONMOUTH JUNCTION, NJ
Yuval A CabillyDirectorMONMOUTH JUNCTION, NJ
Bridget A MartellDirectorMONMOUTH JUNCTION, NJ
Roy A GolanExecutive OfficerMONMOUTH JUNCTION, NJ
Robert A SpiegelDirectorMONMOUTH JUNCTION, NJ
David A SidranskyDirectorMONMOUTH JUNCTION, NJ
Roni A AppelDirectorMONMOUTH JUNCTION, NJ
Ken A BerlinDirectorMonmouth Junction, NJ
Ken A BerlinExecutive OfficerMonmouth Junction, NJ

Other filings by this issuer (13)

FiledFormOfferingSold
2023-11-02D$434K$434K
2021-04-28D$11.1M$11.1M
2012-12-13D$10.0M
2012-06-06D$715K
2012-05-29D$4.5M
2012-02-24D$1.0M
2011-11-15D$2.0M
2011-05-27D$6.0M
2010-11-15D$835K
2010-07-30D$7.5M$7.5M
2009-10-22D$50K
2009-10-05D$5.0M$5.0M
2009-10-01D$962K

More